SMTL ID : 4p4c.1

Human EphA3 Kinase domain in complex with quinoxaline derivatives

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

monomer

Ligands

1 x 25Q: 2-amino-1-(3-methoxyphenyl)-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide(Non-covalent)

25Q.1: 15 residues within 4Å: Chain A: V.41, V.49, A.65, I.66, K.67, E.84, M.88, I.97, I.111, T.113, E.114, Y.115, M.116, L.167, S.177 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:V.49, A:A.65, A:I.97, A:T.113, A:L.167 Hydrogen bonds: A:T.113, A:E.114, A:M.116, A:M.116

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Unzue, A. et al., Pyrrolo[3,2-b]quinoxaline Derivatives as Types I1/2 and II Eph Tyrosine Kinase Inhibitors: Structure-Based Design, Synthesis, and in Vivo Validation. J.Med.Chem. (2014)

Release Date

2014-08-13

Peptides

EPH receptor A3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

EPH receptor A3

Related Entries With Identical Sequence